BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 18667832)

  • 1. The Scribble family in cancer: twentieth anniversary.
    Santoni MJ; Kashyap R; Camoin L; Borg JP
    Oncogene; 2020 Nov; 39(47):7019-7033. PubMed ID: 32999444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The leucine-rich repeat signaling scaffolds Shoc2 and Erbin: cellular mechanism and role in disease.
    Jang H; Stevens P; Gao T; Galperin E
    FEBS J; 2021 Feb; 288(3):721-739. PubMed ID: 32558243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MAGI3 negatively regulates Wnt/β-catenin signaling and suppresses malignant phenotypes of glioma cells.
    Ma Q; Yang Y; Feng D; Zheng S; Meng R; Fa P; Zhao C; Liu H; Song R; Tao T; Yang L; Dai J; Wang S; Jiang WG; He J
    Oncotarget; 2015 Nov; 6(34):35851-65. PubMed ID: 26452219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary epithelial barrier function: some new players and mechanisms.
    Brune K; Frank J; Schwingshackl A; Finigan J; Sidhaye VK
    Am J Physiol Lung Cell Mol Physiol; 2015 Apr; 308(8):L731-45. PubMed ID: 25637609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erbin interacts with Sema4C and inhibits Sema4C-induced epithelial-mesenchymal transition in HK2 cells.
    Zhou QD; Ning Y; Zeng R; Chen L; Kou P; Xu CO; Pei GC; Han M; Xu G
    J Huazhong Univ Sci Technolog Med Sci; 2013 Oct; 33(5):672-679. PubMed ID: 24142719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research resource: identification of novel coregulators specific for thyroid hormone receptor-β2.
    Hahm JB; Privalsky ML
    Mol Endocrinol; 2013 May; 27(5):840-59. PubMed ID: 23558175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desmoglein-1/Erbin interaction suppresses ERK activation to support epidermal differentiation.
    Harmon RM; Simpson CL; Johnson JL; Koetsier JL; Dubash AD; Najor NA; Sarig O; Sprecher E; Green KJ
    J Clin Invest; 2013 Apr; 123(4):1556-70. PubMed ID: 23524970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying novel protein complexes in cancer cells using epitope-tagging of endogenous human genes and affinity-purification mass spectrometry.
    Song J; Hao Y; Du Z; Wang Z; Ewing RM
    J Proteome Res; 2012 Dec; 11(12):5630-41. PubMed ID: 23106643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple SILAC to determine stimulus specific interactions in the Wnt pathway.
    Hilger M; Mann M
    J Proteome Res; 2012 Feb; 11(2):982-94. PubMed ID: 22011079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erbin, a negative regulator in diverse signal pathways.
    Dan L; Shi M; Duan H; Han C; Guo N
    Curr Protein Pept Sci; 2010 Dec; 11(8):759-64. PubMed ID: 21235511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erbin: sorting out ErbB2 receptors or giving Ras a break?
    Kolch W
    Sci STKE; 2003 Sep; 2003(199):pe37. PubMed ID: 12966186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PDZ protein erbin modulates beta-catenin-dependent transcription.
    Ress A; Moelling K
    Eur Surg Res; 2008; 41(3):284-9. PubMed ID: 18667832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Erbin PDZ domain binds with high affinity and specificity to the carboxyl termini of delta-catenin and ARVCF.
    Laura RP; Witt AS; Held HA; Gerstner R; Deshayes K; Koehler MF; Kosik KS; Sidhu SS; Lasky LA
    J Biol Chem; 2002 Apr; 277(15):12906-14. PubMed ID: 11821434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hemidesmosomal protein bullous pemphigoid antigen 1 and the integrin beta 4 subunit bind to ERBIN. Molecular cloning of multiple alternative splice variants of ERBIN and analysis of their tissue expression.
    Favre B; Fontao L; Koster J; Shafaatian R; Jaunin F; Saurat JH; Sonnenberg A; Borradori L
    J Biol Chem; 2001 Aug; 276(35):32427-36. PubMed ID: 11375975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction partners of the PDZ domain of erbin.
    Ress A; Moelling K
    Protein Pept Lett; 2006; 13(9):877-81. PubMed ID: 17100642
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.